strength lies in its Research and Formulation Development, which
has resulted in development of proprietary technology platforms.
The formulations developed from such technology platforms are unique
as well as superior, offering remarkable benefits over conventional
formulations available in the market. The superiority has been validated
by clinical trials, bioequivalence studies and grants of patent
(Dynapar AQ). As a result of campaigns, Troikaa is accredited by
prestigious institutes like DRDO & DSIR.